Executive Search

Executive Search

Ashford Benjamin is a specialist executive search firm, focusing on legal recruitment and compliance recruitment in Hong Kong and Asia-Pacific, with a global reach...

Legal Recruitment

Legal Recruitment

Our expert advisors have a long history of placing lawyers into high-profile legal jobs in Hong Kong and Asia-Pacific, including private practice jobs and legal counsel jobs

Compliance Search

Compliance Search

Our team place Head of Compliance jobs and Chief Compliance Officer jobs in Hong Kong and Asia-Pacific, into financial services, and multi-national companies...

Industry Leaders

Industry Leaders

Our expert advisors are highly-qualified, experienced professionals who have been recognised as industry leaders in both legal and compliance recruitment...

Testimonials

I have greatly enjoyed working with Ben. He is a conscientious, well-informed and courteous recruiter who understands not only the needs of his clients well but also the needs of candidates. Discussions with Ben are productive and constructive, and I appreciate his efforts always to contribute positively to any situation for all stakeholders involved. I would not hesitate to refer both employers and candidates to Ben for any legal or regulatory needs

Global Financial Institution, Hong Kong: Head of Legal - APAC

Download our 2018 Brochure

Resources

11
Feb

Hong Kong - Convictions In Less Than A Year After The Significant Controllers Register Law Came Into Force

On 7 January 2019, the Companies Registry published highlights of several prosecution cases regarding the convictions in November 2018 of twelve Hong Kong companies for having failed to keep and maintain their significant controllers registers ("SCR") in accordance with the Companies Ordinance (Cap 622) (the "CO"). All the companies convicted were fined.

01
Feb

Hong Kong - New HKEx Rules Spur Bumper Year In Hong Kong Capital Markets, But Lasting Impact Remains Unclear.

In April 2018, the Hong Kong Stock Exchange’s (HKEx) rule amendments permitting the listing of innovative, high-growth companies with dual-class share structures and pre-revenue biotech companies went into effect. The long-awaited amendments also facilitated the secondary listing in Hong Kong of Chinese companies with an existing listing on another stock exchange.